In contrast to the early events, on day 5 after PAN treatment, the excretion of UE-AQP2 was clearly decreased, which was accompanied by decreases in the expression of renal AQP2 and excretion of UE-TSG101 and UE-ALIX. This evidence concerns the gene TSG101 and polyarteritis nodosa.